Lacripep for Corneal Wound Healing Study

NCT06854393 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Corneal Epithelial Wound Healing

Interventions

DRUG: 0.00025% Lacripep ophthalmic solution and Placebo

Sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborators

[object Object]
[object Object]